Entera Bio Ltd.
ENTX
$1.96
-$0.02-1.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.20% | -15.78% | -7.33% | 7.56% | 19.60% |
| Total Depreciation and Amortization | -27.45% | -25.45% | -17.86% | -18.64% | -16.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 48.43% | 63.25% | 49.30% | 23.56% | -0.83% |
| Change in Net Operating Assets | 297.65% | 274.38% | 157.44% | -189.61% | -189.99% |
| Cash from Operations | 9.31% | 15.91% | 6.73% | -18.85% | 8.81% |
| Capital Expenditure | -700.00% | -83.33% | 82.35% | 66.67% | 70.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -700.00% | -83.33% | 82.35% | 66.67% | 93.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 117.12% | 175.52% | -27.18% | 157,680.00% | 157,420.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.50% | 8.97% | 41.03% | -- | -- |
| Cash from Financing | 126.96% | 193.16% | -25.84% | 145,700.00% | 145,440.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14,756.72% | 859.28% | -81.64% | 89.83% | 99.17% |